Assigning clinical meaning to somatic and germ-line whole-exome sequencing data in a prospective cancer precision medicine study
暂无分享,去创建一个
Carrie Cibulskis | Nikhil Wagle | Steven Joffe | Levi A Garraway | Arezou A Ghazani | Tom Nguyen | Amanda Waldron | Lauren Brais | Marisa Welch | Eliezer M Van Allen | Judy E Garber | Stacey Gabriel | Carol Lowenstein | S. Gabriel | L. Garraway | D. Treacy | E. V. Van Allen | Steven M. Corsello | J. Garber | C. Cibulskis | N. Lindeman | S. Joffe | N. Wagle | H. Rana | Ali Amin-Mansour | F. Huang | S. Gray | L. Sholl | F. H. Wilson | A. Ghazani | E. Hiller | V. Rojas-Rudilla | M. Giannakis | Neal I Lindeman | Marios Giannakis | Steven M Corsello | E. Stover | Andrea Garofalo | Lynette M Sholl | Nelly M Oliver | Joseph P St Pierre | Andrea Garofalo | Irene R Rainville | Elaine Hiller | Daniel J Treacy | Vanesa Rojas-Rudilla | Sam Wood | Elizabeth Bair | Michael Parello | Franklin Huang | Frederick H Wilson | Elizabeth H Stover | Huma Q Rana | Alanna J Church | Ali Amin-Mansour | Jennifer Heng | Abigail Santos | Patrick Bauer | Peter Lo | Megan Gorman | Christine A Lydon | Philip McNamara | Stacy W Gray | Pasi A Ja Nne | L. Brais | Nelly Oliver | C. Lowenstein | C. Lydon | M. Welch | Sam Wood | Philip McNamara | Elizabeth Bair | J. Heng | Peter Lo | A. Church | Tom Nguyen | I. Rainville | J. P. St Pierre | Megan Gorman | Abigail A. Santos | Michael Parello | Patrick Bauer | Amanda Waldron | S. M. Corsello | A. Garofalo
[1] Magalie S Leduc,et al. Clinical whole-exome sequencing for the diagnosis of mendelian disorders. , 2013, The New England journal of medicine.
[2] H. Williams,et al. The use of whole-exome sequencing to disentangle complex phenotypes , 2015, European Journal of Human Genetics.
[3] Levi A Garraway,et al. Precision oncology: an overview. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] Dennis C. Friedrich,et al. Whole-exome sequencing and clinical interpretation of formalin-fixed , paraffin-embedded tumor samples to guide precision cancer medicine , 2014 .
[5] Bale,et al. Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.
[6] Nallasivam Palanisamy,et al. Integrative Clinical Sequencing in the Management of Refractory or Relapsed Cancer in Youth. , 2015, JAMA.
[7] Lee T. Sam,et al. Personalized Oncology Through Integrative High-Throughput Sequencing: A Pilot Study , 2011, Science Translational Medicine.
[8] Marc S. Williams,et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing , 2013, Genetics in Medicine.
[9] K. Klooster,et al. Germline Mutations in Predisposition Genes in Pediatric Cancer , 2016 .
[10] Jennifer D. Churchill,et al. Exome-based mapping and variant prioritization for inherited Mendelian disorders. , 2014, American journal of human genetics.
[11] S. Gabriel,et al. Discovery and saturation analysis of cancer genes across 21 tumor types , 2014, Nature.
[12] Tao Wang,et al. Diagnostic Yield of Clinical Tumor and Germline Whole-Exome Sequencing for Children With Solid Tumors. , 2016, JAMA oncology.
[13] Vladimir Vacic,et al. Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response. , 2015, JAMA oncology.
[14] Lisle E. Mose,et al. Germline Analysis from Tumor–Germline Sequencing Dyads to Identify Clinically Actionable Secondary Findings , 2016, Clinical Cancer Research.
[15] Eric Vilain,et al. Clinical exome sequencing for genetic identification of rare Mendelian disorders. , 2014, JAMA.
[16] Donavan T. Cheng,et al. Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNA. , 2016, JAMA oncology.
[17] Nikhil Wagle,et al. Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine. , 2016, American journal of human genetics.
[18] E. Lander,et al. Lessons from the Cancer Genome , 2013, Cell.
[19] Nikhil Wagle,et al. High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing. , 2012, Cancer discovery.
[20] A. Chinnaiyan,et al. Germline Findings in Tumor-Only Sequencing: Points to Consider for Clinicians and Laboratories. , 2016, Journal of the National Cancer Institute.
[21] Theresa Zhang,et al. Personalized Genomic Analyses for Cancer Mutation Discovery and Interpretation. , 2015 .
[22] E. V. Van Allen,et al. Clinical analysis and interpretation of cancer genome data. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] L. Garraway,et al. Oncologists' and Cancer Patients' Views on Whole-Exome Sequencing and Incidental Findings: Results from The CanSeq Study , 2016, Genetics in Medicine.